Azizah S. Bawadood
Al Kharj, 16273, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Mitotic Hub Gene Network in Colorectal Cancer: Integrated Transcriptomic, Protein-Level, and Clinical-Genomic Characterization of a Ten-Gene Signature.
Journal: Genes
Published: June 06, 2026
Renoprotective effects of the erucic acid in experimental diabetic nephropathy: antioxidant, anti-inflammatory, and in silico insights.
Journal: 3 Biotech
Published: March 30, 2026
Correction: Rosiridin prevents cisplatin-induced renal toxicity by inhibiting caspase-3/NF-κB/Bcl-2 signaling pathways in rats and in silico study.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 11, 2026
Synergistic Antitumor Potential of Propolis With 6‑Mercaptopurine and 5‑Fluorouracil.
Journal: Cell biochemistry and function
Published: August 13, 2025
6-Paradol enhances sorafenib's effects against colorectal cancer and promotes active metabolite formation.
Journal: Pathology, research and practice
Published: December 04, 2024
Exploring acemannan-loaded nanogel formulation for the treatment of IMQ-induced psoriasis-like inflammation: In vitro characterization and in vivo efficacy assessment.
Journal: International immunopharmacology
Published: November 11, 2024
Barbigerone against Lipopolysaccharide-Induced Memory Deficit in Rats via Alteration of Inflammatory and Oxidative Stress Pathway: In vivo, Molecular Docking and Molecular Dynamics Simulations Study.
Journal: CNS & neurological disorders drug targets
Published: August 06, 2024
Rosiridin prevents cisplatin-induced renal toxicity by inhibiting caspase-3/NF-κB/ Bcl-2 signaling pathways in rats and in silico study.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 17, 2024
6-Shogaol improves sorafenib efficacy in colorectal cancer cells by modulating its cellular accumulation and metabolism.
Journal: Pathology, research and practice
Published: March 25, 2024
Butin attenuates behavioral disorders via cholinergic/BDNF/Caspase-3 pathway in scopolamine-evoked memory deficits in rats.
Journal: European review for medical and pharmacological sciences
Published: February 20, 2024
6-shogaol against 3-Nitropropionic acid-induced Huntington's disease in rodents: Based on molecular docking/targeting pro-inflammatory cytokines/NF-κB-BDNF-Nrf2 pathway.
Journal: PloS one
Published: February 17, 2024
In vivo and computational investigation of butin against alloxan-induced diabetes via biochemical, histopathological, and molecular interactions.
Journal: Scientific reports
Published: January 23, 2024
Last Updated: 09/26/2026